Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections.

@article{Russo2016CurrentAF,
  title={Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections.},
  author={Alessandro Russo and Ercole Concia and Francesco Cristini and F. G. De Rosa and Silvano Esposito and Francesco Menichetti and Nicola Petrosillo and Mario Tumbarello and Mario Venditti and Pierluigi Viale and Claudio Viscoli and Matteo Bassetti},
  journal={Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases},
  year={2016},
  volume={22 Suppl 2},
  pages={
          S27-36
        }
}
In 2013 the US Food and Drug Administration (FDA) issued recommendations and guidance on developing drugs for treatment of skin infection using a new definition of acute bacterial skin and skin-structure infection (ABSSSI). The new classification includes cellulitis, erysipelas, major skin abscesses and wound infection with a considerable extension of skin involvement, clearly referring to a severe subset of skin infections. The main goal of the FDA was to better identify specific infections… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 17 CITATIONS

Current Treatment Options for Acute Skin and Skin-structure Infections

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2019
VIEW 8 EXCERPTS
CITES METHODS & BACKGROUND
HIGHLY INFLUENCED

Current Epidemiology, Etiology, and Burden of Acute Skin Infections in the United States

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2019
VIEW 4 EXCERPTS
CITES METHODS, BACKGROUND & RESULTS
HIGHLY INFLUENCED

Comparative In Vitro Activities of New Antibiotics for the Treatment of Skin Infections

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2019
VIEW 1 EXCERPT
CITES BACKGROUND

Management of complicated skin and soft tissue infections with a special focus on the role of newer antibiotics

Hoe Nam Leong, Asok Kurup, +3 authors Mark H Wilcox
  • Infection and drug resistance
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 66 REFERENCES

A Randomized Clinical Trial of Single-Dose Versus Weekly Dalbavancin for Treatment of Acute Bacterial Skin and Skin Structure Infection.

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2016
VIEW 1 EXCERPT

A Randomized Trial of Clindamycin Versus Trimethoprim-sulfamethoxazole for Uncomplicated Wound Infection.

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2016
VIEW 1 EXCERPT

The Medicines Company announces positive results for SOLO II trial of oritavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSI) [news release

The Medicines Company
  • Available at: http://ir.themedicinescompany.com/phoenix. zhtml?c1⁄4122204&p1⁄4irol-newsArticle&ID1⁄41834647&highlight1⁄4. Accessed
  • 2015
VIEW 1 EXCERPT

Similar Papers

Loading similar papers…